Differences in sulfation patterns of heparan sulfate derived from human bone marrow and umbilical vein endothelial cells

Experimental Hematology

Volumn 29, Issue 7, 2001, Pages 884-893

  Netelenbos, Tanja ^a   Dräger, Angelika M ^a   Van het Hof, Bert ^b   Kessler, Floortje L ^a   Delouis, Claude ^c   Huijgens, Peter C ^a   Van den Born, Jacob ^b   Van Dijk, Willem ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE;

BONE MARROW CELL; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; SULFATION; UMBILICAL VEIN;

BONE MARROW; ENDOTHELIUM, VASCULAR; HEPARITIN SULFATE; HUMANS; ORGAN SPECIFICITY; VEINS;

EID: 0034959195     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00653-1     Document Type: Conference Paper

References (54)

1. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues
2. Adhesion receptors on bone marrow stromal cells; in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice
3. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow
4. Hematopoietic progenitor cell rolling in bone marrow microvessels; parallel contributions by endothelial selectins and vascular cell adhesion molecule 1
5. Regulated diversity of heparan sulfate
6. Structure-activity relationship of heparan sulphate
7. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species
8. Glycosaminoglycans; molecular properties, protein interactions, and role in physiological processes
9. More to 'heparin' than anticoagulation
10. Heparin structure and interactions with basic fibroblast growth factor
11. The purification and mechanism of action of human antithrombin-heparin cofactor
12. Defining the interleukin-8-binding domain of heparan sulfate
13. Differential binding of chemokines to glycosaminoglycan subpopulations
14. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta
15. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow
16. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
17. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow
18. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants; stromal cell-derived factor-1, steel factor, and the bone marrow environment
19. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
20. Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1α
21. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine
22. Monocyte adhesion to activated aortic endothelium; role of L-selectin and heparan sulfate proteoglycans
23. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18)
24. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate
25. Isolation and characterization of human bone marrow microvascular endothelial cells; hematopoietic progenitor cell adhesion
26. Isolation and culture of human bone marrow endothelial cells
27. Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene
28. Characterization of a newly established human bone marrow endothelial cell line; distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells
29. Adhesion of hematopoietic progenitor cells to human bone marrow or umbilical vein derived endothelial cell lines; a comparison
30. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
31. Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture
32. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry
33. Formation of anhydrosugars in the chemical depolymerization of heparin
34. Effects of (2-6)-linked sialic acid and (1-3)-linked fucose on the interaction of N-linked glycopeptides and related oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating levtin (l-PHA)
35. Monoclonal antibodies to heparan sulfate proteoglycan; development and application to the study of normal tissue and pathologic human kidney biopsies
36. Developmental changes in heparan sulfate expression; in situ detection with mAbs
37. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney
38. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate
39. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells
40. Identification of the core proteins in proteoglycans synthesized by vascular endothelial cells
41. Role of heparan sulfate in immune system-blood vessel interactions
42. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis
43. Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation
44. Heparan sulfates from Swiss mouse 3T3 and SV3T3 cells; O-sulfate difference
45. Characterization of extracellular matrix-associated glycosaminoglycans produced by untransformed and transformed bovine corneal endothelial cells in culture
46. Molecular structure of heparan sulphate synthesised by bovine aortic endothelial cells
47. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate
48. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures
49. Production of heparan sulphate proteoglycans by human bone marrow stromal cells
50. Proteoglycan synthesis in haematopoietic cells; isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5
51. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche
52. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates; requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins
53. Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate
54. Domain structure of endothelial heparan sulphate